title: MRI contrast agents for evaluating focal hepatic lesions.
abstract: Contrast-enhanced magnetic resonance imaging (MRI) has become an important tool in the detection and characterization of focal hepatic lesions especially when other investigations such as ultrasound (US) and computed tomography (CT) are inconclusive. The purpose of this pictorial review is to briefly summarize the properties of various MRI contrast agents used in hepatic imaging and to highlight their role in evaluation of focal hepatic lesions.
authors.affiliation: Department of Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. mharisinghani@partners.org
authors.forename: M G
authors.initials: MG
authors.lastname: Harisinghani
authors.forename: K S
authors.initials: KS
authors.lastname: Jhaveri
authors.forename: R
authors.initials: R
authors.lastname: Weissleder
authors.forename: W
authors.initials: W
authors.lastname: Schima
authors.forename: S
authors.initials: S
authors.lastname: Saini
authors.forename: P F
authors.initials: PF
authors.lastname: Hahn
authors.forename: P R
authors.initials: PR
authors.lastname: Mueller
mesh_terms: D003287:Contrast Media; D005260:Female; D006801:Humans; D006965:Hyperplasia / Q000175:diagnosis; D008099:Liver / Q000473:pathology; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000556:secondary; D008279:Magnetic Resonance Imaging / Q000379:methods*
chemical_list: D003287:Contrast Media